<ul>
<li>核能、制药与旅游回购：信心还是谨慎的信号？</li>
</ul>
<p>根据 MarketBeat 的股票筛选工具，礼来公司、雅培和艾伯维是今天值得关注的三只制药股票。制药股票是指那些研究、开发、生产和销售处方药、疫苗及其他治疗产品的上市公司股票。它们包括大型综合制药公司以及专注于特定疗法的小型生物技术公司。对于投资者而言，这些股票通常受到临床试验结果、监管批准、专利到期和定价/政策变化的驱动，创造出二元的上行潜力以及较高的波动性和风险。这些公司在过去几天内的交易量是所有制药股票中最高的。</p>
<p>获取 <strong>礼来公司</strong> 的提醒：</p>
<h2>礼来公司 (LLY)</h2>
<p>礼来公司在全球范围内发现、开发和销售人用药物。该公司提供 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰岛素利普罗、胰岛素利普罗原料、胰岛素利普罗混合 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500 用于糖尿病；Jardiance、Mounjaro 和 Trulicity 用于 2 型糖尿病；Zepbound 用于肥胖。</p>
<ul>
<li>礼来的下一个帝国：对人工智能和神经科学的 100 亿美元投资</li>
</ul>
<p>阅读我们关于 LLY 的最新研究报告</p>
<h2>雅培 (ABT)</h2>
<p>雅培公司及其子公司在全球范围内发现、开发、生产和销售医疗保健产品。它分为四个部门：成熟药品、诊断产品、营养产品和医疗器械。该公司提供用于治疗胰腺外分泌功能不全、肠易激综合症或胆道痉挛、肝内胆汁淤积或抑郁症、妇科疾病、激素替代疗法、血脂异常、高血压、甲状腺功能减退、梅尼埃病和前庭性眩晕、疼痛、发热、炎症和偏头痛的仿制药，以及提供抗感染药物克拉霉素、流感疫苗和调节结肠生理节律的产品。</p>
<ul>
<li>默克刚刚在一个新的癌症增长引擎上进行了重大投资</li>
</ul>
<p>阅读我们关于 ABT 的最新研究报告</p>
<h2>艾伯维 (ABBV)</h2>
<p>艾伯维公司在全球范围内发现、开发、生产和销售药品。该公司提供 Humira，一种用于自身免疫性和肠道贝赫切特病及脓皮病的注射药物；Skyrizi 用于治疗中度至重度斑块型银屑病、银屑病性疾病和克罗恩病；Rinvoq 用于治疗类风湿性关节炎和银屑病性关节炎、强直性脊柱炎、特应性皮炎、轴性脊柱关节病、溃疡性结肠炎和克罗恩病；Imbruvica 用于治疗成人血癌；Epkinly 用于治疗淋巴瘤；Elahere 用于治疗癌症；Venclexta/Venclyxto 用于治疗血癌。</p>
<p>阅读我们关于 ABBV 的最新研究报告</p>
<h2>推荐故事</h2>
<ul>
<li>MarketBeat 2026 年 4 月值得拥有的五大股票</li>
<li>随着耐克股票接近 12 年低点，现在是勇敢出手的时候吗？</li>
<li>三家不同的金融科技巨头：转型、稳定还是冒险投资？</li>
<li>微软的 Copilot 问题并不是你想的那样</li>
<li>2026 年三只令人惊讶的标普 500 超越者</li>
<li>罗素 2000 追踪新高：ETF 交易者接下来会怎样？</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在礼来公司吗？</h2>
<p>在你考虑礼来公司之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议现在购买，以便在更广泛的市场注意到之前……而礼来公司并不在名单上。</p>
<p>虽然礼来公司目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

医疗业 ETF - Vanguard

基因改革 ETF - ARK

医疗业 ETF - SPDR

<p>根据 MarketBeat 的报道，礼来、雅培和艾伯维被认为是值得关注的顶级制药股票。这些公司涉及开发和销售各种医疗产品，包括糖尿病药物和自身免疫疾病的治疗。它们的股票受到临床试验、监管变化和市场动态的影响，因此既是有前景的投资，也具有波动性。尽管礼来获得了适度买入评级，但分析师建议其他股票可能提供更好的投资机会</p>

<ul>
<li>Nuclear, Pharma &amp; Travel Buybacks: Confident or Cautious Signals?</li>
</ul>
<div class="lb-trans"><ul>
<li>核能、制药与旅游回购：信心还是谨慎的信号？</li>
</ul>
</div><p>Eli Lilly and Company, Abbott Laboratories, and AbbVie are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies that research, develop, manufacture, and sell prescription drugs, vaccines, and other therapeutic products. They include large integrated drugmakers as well as smaller biotechnology firms focused on specific therapies. For investors these stocks are often driven by clinical trial results, regulatory approvals, patent expirations and pricing/policy changes, creating both binary upside potential and elevated volatility and risk. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.</p>
<div class="lb-trans"><p>根据 MarketBeat 的股票筛选工具，礼来公司、雅培和艾伯维是今天值得关注的三只制药股票。制药股票是指那些研究、开发、生产和销售处方药、疫苗及其他治疗产品的上市公司股票。它们包括大型综合制药公司以及专注于特定疗法的小型生物技术公司。对于投资者而言，这些股票通常受到临床试验结果、监管批准、专利到期和定价/政策变化的驱动，创造出二元的上行潜力以及较高的波动性和风险。这些公司在过去几天内的交易量是所有制药股票中最高的。</p>
</div><p>Get <strong>Eli Lilly and Company</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>礼来公司</strong> 的提醒：</p>
</div><h2>Eli Lilly and Company (LLY)</h2>
<div class="lb-trans"><h2>礼来公司 (LLY)</h2>
</div><p>Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.</p>
<div class="lb-trans"><p>礼来公司在全球范围内发现、开发和销售人用药物。该公司提供 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰岛素利普罗、胰岛素利普罗原料、胰岛素利普罗混合 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500 用于糖尿病；Jardiance、Mounjaro 和 Trulicity 用于 2 型糖尿病；Zepbound 用于肥胖。</p>
</div><ul>
<li>Lilly's Next Empire: A $10 Billion Bet on AI and Neuroscience</li>
</ul>
<div class="lb-trans"><ul>
<li>礼来的下一个帝国：对人工智能和神经科学的 100 亿美元投资</li>
</ul>
</div><p>Read Our Latest Research Report on LLY</p>
<div class="lb-trans"><p>阅读我们关于 LLY 的最新研究报告</p>
</div><h2>Abbott Laboratories (ABT)</h2>
<div class="lb-trans"><h2>雅培 (ABT)</h2>
</div><p>Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.</p>
<div class="lb-trans"><p>雅培公司及其子公司在全球范围内发现、开发、生产和销售医疗保健产品。它分为四个部门：成熟药品、诊断产品、营养产品和医疗器械。该公司提供用于治疗胰腺外分泌功能不全、肠易激综合症或胆道痉挛、肝内胆汁淤积或抑郁症、妇科疾病、激素替代疗法、血脂异常、高血压、甲状腺功能减退、梅尼埃病和前庭性眩晕、疼痛、发热、炎症和偏头痛的仿制药，以及提供抗感染药物克拉霉素、流感疫苗和调节结肠生理节律的产品。</p>
</div><ul>
<li>Merck Just Made a Big Bet on a New Cancer Growth Engine</li>
</ul>
<div class="lb-trans"><ul>
<li>默克刚刚在一个新的癌症增长引擎上进行了重大投资</li>
</ul>
</div><p>Read Our Latest Research Report on ABT</p>
<div class="lb-trans"><p>阅读我们关于 ABT 的最新研究报告</p>
</div><h2>AbbVie (ABBV)</h2>
<div class="lb-trans"><h2>艾伯维 (ABBV)</h2>
</div><p>AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.</p>
<div class="lb-trans"><p>艾伯维公司在全球范围内发现、开发、生产和销售药品。该公司提供 Humira，一种用于自身免疫性和肠道贝赫切特病及脓皮病的注射药物；Skyrizi 用于治疗中度至重度斑块型银屑病、银屑病性疾病和克罗恩病；Rinvoq 用于治疗类风湿性关节炎和银屑病性关节炎、强直性脊柱炎、特应性皮炎、轴性脊柱关节病、溃疡性结肠炎和克罗恩病；Imbruvica 用于治疗成人血癌；Epkinly 用于治疗淋巴瘤；Elahere 用于治疗癌症；Venclexta/Venclyxto 用于治疗血癌。</p>
</div><p>Read Our Latest Research Report on ABBV</p>
<div class="lb-trans"><p>阅读我们关于 ABBV 的最新研究报告</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>MarketBeat's Top Five Stocks to Own in April 2026</li>
<li>With Nike Shares Near a 12-Year Low, Is Now the Time to Be Brave?</li>
<li>3 Different Fintech Giants: Turnaround, Stability, or Risky Bet?</li>
<li>Microsoft’s Copilot Problem Isn’t What You Think</li>
<li>3 Surprising S&amp;P 500 Outperformers of 2026</li>
<li>Russell 2000 Tracking for New Highs: What’s Next for ETF Traders?</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 2026 年 4 月值得拥有的五大股票</li>
<li>随着耐克股票接近 12 年低点，现在是勇敢出手的时候吗？</li>
<li>三家不同的金融科技巨头：转型、稳定还是冒险投资？</li>
<li>微软的 Copilot 问题并不是你想的那样</li>
<li>2026 年三只令人惊讶的标普 500 超越者</li>
<li>罗素 2000 追踪新高：ETF 交易者接下来会怎样？</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Eli Lilly and Company Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在礼来公司吗？</h2>
</div><p>Before you consider Eli Lilly and Company, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑礼来公司之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议现在购买，以便在更广泛的市场注意到之前……而礼来公司并不在名单上。</p>
</div><p>While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然礼来公司目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

4 月 12 日值得关注的最佳制药股票